Eledon Pharmaceuticals Cash Flow Statement (2013-2026) | ELDN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-7.38M	-9.82M	28.25M	-9.86M	-9.25M	-10.47M	-58.38M	-11.11M	-10.35M	-11.20M	8.19M	-10.87M	-14.50M	-20.51M	38.37M	-17.96M	-24.73M	-19.07M		-21.18M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	2.03M	2.04M	2.05M	2.19M	2.31M	2.19M	1.47M	1.38M	1.72M	1.73M	1.71M	1.69M	3.06M	1.78M	6.58M	2.86M	2.69M	2.43M	2.46M	2.20M
Gains from Investment Securities (Quarter)													31.27M	-96.44M	52.26M	-10.06M	-12.29M	-0.56M	22.92M	18.96M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-7.45M	-7.09M	-9.21M	-8.16M	-6.22M	-4.57M	-9.48M	-9.92M	-8.22M	-12.25M	-9.13M	-8.74M	-7.77M	-11.77M	-18.99M	-16.06M	-17.71M	-14.48M	-14.09M	-22.61M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	-1.61M	1.37M	0.16M	-1.40M	0.36M	2.91M	0.21M
Other Working Capital Changes (Quarter)	-0.05M	0.15M	-0.26M	-0.09M	-1.19M	-0.80M	1.43M	-0.08M	-0.71M	1.15M	-0.72M	-0.10M	-0.07M	-1.52M	1.35M	-0.07M	-0.08M	-0.39M	-0.70M	-0.09M
Investing Activities
Capital Expenditures (Quarter)
Change in Acquisitions & Divestments (Quarter)											28.00M	22.70M	16.40M	21.32M	25.40M	35.74M	42.36M	45.06M	48.76M	49.08M
Cash from Investing Activities (Quarter)										-25.03M	10.08M	9.78M	-19.91M	-12.80M	-47.38M	3.89M	14.96M	12.40M	-20.46M	5.96M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)		0.00M										0.00M	48.07M	5.28M	80.17M	0.12M			53.69M
Additional items
Change in Cash (Quarter)	-7.45M	-7.09M	-9.21M	-8.16M	-6.22M	-4.57M	-9.48M	-9.92M	-5.54M	-37.28M	0.94M	1.04M	20.38M	-19.29M	13.80M	-12.05M	-2.75M	-2.07M	19.14M	-16.66M
Free Cash Flow (Quarter)	-7.45M	-7.09M	-9.21M	-8.16M	-6.22M	-4.57M	-9.48M	-9.92M	-8.22M	-12.25M	-9.13M	-8.74M	-7.77M	-11.77M	-18.99M	-16.06M	-17.71M	-14.48M	-14.09M	-22.61M
Net Cash Flow (Quarter)	-7.45M	-7.09M	-9.21M	-8.16M	-6.22M	-4.57M	-9.48M	-9.92M	-8.22M	-37.28M	0.94M	1.04M	20.38M	-19.29M	13.80M	-12.05M	-2.75M	-2.07M	19.14M	-16.66M

Research Tools

Eledon Pharmaceuticals Cash Flow Statement (2013-2026) | ELDN

Create an account

Sign In

Reset Password